Correlation Between Eliem Therapeutics and IO Biotech
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and IO Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and IO Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and IO Biotech, you can compare the effects of market volatilities on Eliem Therapeutics and IO Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of IO Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and IO Biotech.
Diversification Opportunities for Eliem Therapeutics and IO Biotech
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Eliem and IOBT is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and IO Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IO Biotech and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with IO Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IO Biotech has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and IO Biotech go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and IO Biotech
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the IO Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.81 times less risky than IO Biotech. The stock trades about -0.29 of its potential returns per unit of risk. The IO Biotech is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 82.00 in IO Biotech on September 11, 2024 and sell it today you would earn a total of 2.00 from holding IO Biotech or generate 2.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.31% |
Values | Daily Returns |
Eliem Therapeutics vs. IO Biotech
Performance |
Timeline |
Eliem Therapeutics |
IO Biotech |
Eliem Therapeutics and IO Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eliem Therapeutics and IO Biotech
The main advantage of trading using opposite Eliem Therapeutics and IO Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, IO Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IO Biotech will offset losses from the drop in IO Biotech's long position.Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
IO Biotech vs. Pmv Pharmaceuticals | IO Biotech vs. Eliem Therapeutics | IO Biotech vs. MediciNova | IO Biotech vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |